Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

413
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
413
Cross-reactivity00:42

Cross-reactivity

31.4K
Overview
31.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthesis of chlorophyll b: a retrospective analysis of chlorophyllide a oxygenase.

Photosynthesis research·2026
Same author

Glycomimetic Peptides as Therapeutic Tools.

Pharmaceutics·2023
Same author

The Discovery and Function of Filaggrin.

International journal of molecular sciences·2022
Same author

Editorial: Sentinel CLECs at Immunological Decision Nodes.

Frontiers in immunology·2020
Same author

ASGR1 and Its Enigmatic Relative, CLEC10A.

International journal of molecular sciences·2020
Same author

Stories From the Dendritic Cell Guardhouse.

Frontiers in immunology·2020

Related Experiment Video

Updated: Aug 30, 2025

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation
02:36

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation

Published on: March 8, 2024

1.1K

Resolution of Eczema with Multivalent Peptides.

Laura L Eggink1, J Kenneth Hoober1

  • 1Susavion Biosciences, Tempe, Arizona, USA.

JID Innovations : Skin Science From Molecules to Population Health
|August 30, 2022
PubMed
Summary
This summary is machine-generated.

A novel peptide, svL4, effectively resolves severe eczema in mice by restoring skin barrier integrity. This tetravalent peptide treatment eliminated neutrophils and normalized epidermal morphology within 14 days, suggesting a powerful therapeutic potential for eczema.

Keywords:
Ca2+, calcium ionDex, dexamethasoneHDM, house dust miteKC, keratinocyteLPS, lipopolysaccharideSEB, Staphylococcal enterotoxin BTGM, transglutaminase

More Related Videos

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
09:42

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

7.5K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.6K

Related Experiment Videos

Last Updated: Aug 30, 2025

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation
02:36

Author Spotlight: Effective Reuse of Polycarbonate Tubes for Extracellular Vesicle Isolation

Published on: March 8, 2024

1.1K
Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
09:42

Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research

Published on: April 19, 2017

7.5K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

10.6K

Area of Science:

  • Dermatology
  • Immunology
  • Biochemistry

Background:

  • Skin barrier disruption is a key factor in eczema development, allowing allergens and irritants to trigger inflammatory responses.
  • Eczema is characterized by epidermal thickening, disruption, and neutrophil infiltration in the dermis.
  • Current treatments may not fully restore normal skin morphology.

Purpose of the Study:

  • To investigate the efficacy of a novel tetravalent peptide, svL4, in resolving experimentally induced eczema in mice.
  • To compare the effects of svL4 with a peptide mimetic of sialic acid (svH1C) and dexamethasone.
  • To elucidate the mechanism by which svL4 restores skin barrier function.

Main Methods:

  • Eczema was induced on mouse skin using topical lipopolysaccharide or a mixture of Staphylococcal enterotoxin B and house dust mite extract.
  • Affected skin was treated topically with 1 μM svL4, 1 μM svH1C, or 1 μM dexamethasone.
  • Skin morphology, epidermal thickness, and neutrophil presence were assessed after 14 days of treatment.

Main Results:

  • Topical svL4 treatment (1 μM) significantly reduced epidermal thickening and neutrophil infiltration within 14 days.
  • svL4 treatment restored normal epidermal morphology in the affected skin.
  • svH1C and dexamethasone treatments were ineffective in restoring normal epidermal morphology.
  • svL4's efficacy is linked to its glutamine residues, which act as a substrate for transglutaminase 2 at the skin surface.

Conclusions:

  • The tetravalent peptide svL4 demonstrates potent therapeutic potential for resolving severe eczema.
  • svL4 effectively restores skin barrier integrity by normalizing epidermal morphology and reducing inflammation.
  • The mechanism involves transglutaminase 2-mediated cross-linking, highlighting a targeted approach for eczema treatment.